Prosecution Insights
Last updated: April 19, 2026

Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18613714 GLP-1 Receptor Agonist and Composition and Use Thereof HABTE, KAHSAY 1624 Final Rejection Mar 22, 2024
18264400 FERMENTATION METHOD FOR MUPIROCIN KOROTCHKINA, LIOUBOV G 1653 Non-Final OA Aug 04, 2023

Managing Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month